INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

TMDXTransMedics Group, Inc.

CIK 0001756262

EDGAR filingsOpen in network
Disclosed transactions0
Buys / sells0 / 0
Max Insider Score—
Connections2with evidence

TMDX · disclosed activity on price

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3845 · Electromedical & Electrotherapeutic Apparatus · Nov 4, 2026
  • ← Lobbied forevidence
    AKIN GUMP STRAUSS HAUER & FELDLDA Q2 2026 second quarter · MED · Aug 26, 2026

Lobbying

$260K reported · de-duplicated
2026 Q2 $130K via firms2026 Q1 $130K via firms
  • AKIN GUMP STRAUSS HAUER & FELD$130K2026 Q1 · posted Aug 26, 2026 · MED
  • AKIN GUMP STRAUSS HAUER & FELD—2026 Q1 · posted Aug 26, 2026 · MED
  • AKIN GUMP STRAUSS HAUER & FELD$130K2026 Q2 · posted Aug 26, 2026 · MED

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.